https://www.thebodypro.com/category/prep-hiv-pre-exposure-prophylasxis/tag/conference-coverage

The Latest

Mexico City's Downtown At Twilight

IAS 2019: What to Expect in HIV Science

Next week, 6,000 HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.

Staying on PrEP is Significantly Different for PrEP Users With Commercial Insurance Versus Medicaid Img

Staying on PrEP is Significantly Different for PrEP Users With Commercial Insurance Versus Medicaid

Young adults, blacks, cisgender women, and people in rural areas, as well as people on Medicaid, were less likely to persist on PrEP.

CROI 2019: What News to Expect in HIV Science and Policy

TheBodyPro is covering all the latest in HIV science at the biggest annual gathering of HIV researchers in the U.S. Here's a preview of what's to come.

Quote from NIAID's Carl Dieffenbach

HIV Prevention Research Highlights From HIVR4P 2018

At last week's HIV Research for Prevention (HIVR4P) conference in Madrid, scientists reported progress in numerous areas of HIV prevention research.

How to Evaluate PrEP and Vaccines: Urgency for Next-Generation Compounds Img

How to Evaluate PrEP and Vaccines: Urgency for Next-Generation Compounds

Several presentations at the 2018 HIV Research for Prevention conference looked at the new challenges of evaluating efficacy of new PrEP and vaccine candidates.

blood vials

Blood, Hair, or Urine? Weighing PrEP Adherence Options Beyond Self-Report

There are a number of measures determine adherence to PrEP, each with benefits and drawbacks. Currently, no one guideline or definitive standard is being used.

Retaining Patients in PrEP Care Faces Many Hurdles, Studies Show Img

Retaining Patients in PrEP Care Faces Many Hurdles, Studies Show

Most people who could benefit from pre-exposure prophylaxis are not accessing it, the U.S. Centers for Disease Control and Prevention revealed at this year's Conference on Retroviruses and Opportunistic Infections.

Attendees in the poster hall at CROI 2018

Reported PrEP 'Failure' Most Likely a Lack of Proper Testing and Adherence

When is a pre-exposure prophylaxis (PrEP) failure actually a provider failure? And how do we tell the difference?

HIV prevention pill is not reaching most who could potentially benefit -- especially African Americans and Latinos

CDC: Few People Who Could Benefit From PrEP Are Using It

The CDC has released new data at the Conference on Retroviruses and Opportunistic Infections (CROI) estimating that only a small percentage of people most at risk for HIV infection have actually been prescribed pre-exposure prophylaxis (PrEP).

Attendees observe a session at IDWeek 2017

PrEP Prescriptions Rise Sharply, but Unequally, in New York City

In New York City, the number of people taking PrEP has skyrocketed in recent years -- yet prescriptions are more likely to be written for affluent white men than others, research finds.